I-1 Imidazoline Receptor

[1]  J. García-Sevilla,et al.  Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: possible involvement of imidazoline-preferring receptors , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  D. Moura,et al.  Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  D. Urošević,et al.  [125I]2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptors. , 2002, Molecular pharmacology.

[4]  D. Nutt,et al.  β-carboline binding to imidazoline receptors , 2001 .

[5]  J. Piletz,et al.  Autoradiographic Comparison of [3H]-Clonidine Binding to Non-Adrenergic Sites and α2-Adrenergic Receptors in Human Brain , 2000, Neuropsychopharmacology.

[6]  B. Roth,et al.  Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. , 2000, DNA and cell biology.

[7]  J. Kapocsi,et al.  Imidazoline receptors: from discovery to antihypertensive therapy (facts and doubts) , 1999, Brain Research Bulletin.

[8]  P. Ernsberger,et al.  Imidazoline Receptor Antisera‐Selected cDNA Clone and mRNA Distribution a , 1999, Annals of the New York Academy of Sciences.

[9]  S. Penner,et al.  Peripheral and Central Imidazoline Receptor‐Mediated Natriuresis in the Rat a , 1999, Annals of the New York Academy of Sciences.

[10]  P. Ernsberger.  The I1‐Imidazoline Receptor and Its Cellular Signaling Pathways a , 1999, Annals of the New York Academy of Sciences.

[11]  P. Escribá,et al.  Pharmacologic Characterization of Imidazoline Receptor Proteins Identified by Immunologic Techniques and Other Methods a , 1999, Annals of the New York Academy of Sciences.

[12]  T. Mammoto,et al.  The involvement of pertussis toxin‐sensitive G proteins in the post receptor mechanism of central I1‐imidazoline receptors , 1997, British journal of pharmacology.

[13]  G. Molderings.  IMIDAZOLINE RECEPTORS : BASIC KNOWLEDGE, RECENT ADVANCES AND FUTURE PROSPECTS FOR THERAPY AND DIAGNOSIS , 1997 .

[14]  J. Piletz,et al.  Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. , 1996, The Journal of pharmacology and experimental therapeutics.

[15]  J. Piletz,et al.  Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. , 1996, Journal of psychiatric research.

[16]  J. Piletz,et al.  Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. , 1996, Journal of psychiatric research.

[17]  D. Reis,et al.  Imidazoline receptors and their endogenous ligands. , 1996, Annual review of pharmacology and toxicology.

[18]  D. Reis,et al.  Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.

[19]  J. Piletz,et al.  Increased imidazoline and α 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes , 1993, Biological Psychiatry.

[20]  M. Dontenwill,et al.  Imidazoline receptors. A new concept in central regulation of the arterial blood pressure. , 1992, American journal of hypertension.

[21]  Y. Burstein,et al.  Isolation and partial purification of a clonidine-displacing endogenous brain substance. , 1984, European journal of biochemistry.